Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 9.13301980 |
2 | central nervous system myelination (GO:0022010) | 9.13301980 |
3 | fatty acid elongation (GO:0030497) | 6.28728068 |
4 | myelin maintenance (GO:0043217) | 5.44276250 |
5 | synaptic vesicle maturation (GO:0016188) | 5.44220153 |
6 | cellular potassium ion homeostasis (GO:0030007) | 5.24390564 |
7 | sodium ion export (GO:0071436) | 5.10684257 |
8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.88342652 |
9 | synaptic vesicle exocytosis (GO:0016079) | 4.87522971 |
10 | ensheathment of neurons (GO:0007272) | 4.86064203 |
11 | axon ensheathment (GO:0008366) | 4.86064203 |
12 | myelination (GO:0042552) | 4.85446703 |
13 | response to lipoprotein particle (GO:0055094) | 4.68753012 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67936143 |
15 | L-phenylalanine catabolic process (GO:0006559) | 4.67936143 |
16 | response to redox state (GO:0051775) | 4.66973109 |
17 | locomotory exploration behavior (GO:0035641) | 4.65769991 |
18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.63925686 |
19 | glutamate secretion (GO:0014047) | 4.61903681 |
20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.56976109 |
21 | potassium ion import (GO:0010107) | 4.44246683 |
22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.11539767 |
23 | neuronal ion channel clustering (GO:0045161) | 4.08248709 |
24 | postsynaptic membrane organization (GO:0001941) | 4.04769188 |
25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.03633950 |
26 | L-phenylalanine metabolic process (GO:0006558) | 4.03633950 |
27 | potassium ion homeostasis (GO:0055075) | 3.98329014 |
28 | regulation of synaptic vesicle transport (GO:1902803) | 3.91870318 |
29 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.88648811 |
30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.83561536 |
31 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.82472278 |
32 | cerebellar granule cell differentiation (GO:0021707) | 3.80020472 |
33 | cholesterol biosynthetic process (GO:0006695) | 3.79885385 |
34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.78364180 |
35 | oligodendrocyte differentiation (GO:0048709) | 3.77900448 |
36 | amyloid precursor protein catabolic process (GO:0042987) | 3.77884427 |
37 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.72422835 |
38 | very long-chain fatty acid metabolic process (GO:0000038) | 3.67237824 |
39 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.64549200 |
40 | amyloid precursor protein metabolic process (GO:0042982) | 3.59909815 |
41 | regulation of synapse structural plasticity (GO:0051823) | 3.58590656 |
42 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.57880535 |
43 | eye photoreceptor cell differentiation (GO:0001754) | 3.57642061 |
44 | photoreceptor cell differentiation (GO:0046530) | 3.57642061 |
45 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.56705755 |
46 | creatine metabolic process (GO:0006600) | 3.55436743 |
47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.54991055 |
48 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.52584053 |
49 | exploration behavior (GO:0035640) | 3.51249652 |
50 | neurotransmitter secretion (GO:0007269) | 3.50381801 |
51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.48453476 |
52 | import into cell (GO:0098657) | 3.47429394 |
53 | regulation of ARF protein signal transduction (GO:0032012) | 3.46712341 |
54 | neuromuscular process controlling balance (GO:0050885) | 3.43292923 |
55 | neurotransmitter uptake (GO:0001504) | 3.40310464 |
56 | presynaptic membrane assembly (GO:0097105) | 3.39730164 |
57 | response to methylmercury (GO:0051597) | 3.38008170 |
58 | regulation of cholesterol esterification (GO:0010872) | 3.37570686 |
59 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.36826705 |
60 | sterol biosynthetic process (GO:0016126) | 3.35009597 |
61 | regulation of lipoprotein metabolic process (GO:0050746) | 3.31687141 |
62 | neuron cell-cell adhesion (GO:0007158) | 3.30583875 |
63 | negative regulation of inclusion body assembly (GO:0090084) | 3.29907690 |
64 | astrocyte differentiation (GO:0048708) | 3.25397843 |
65 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.24333253 |
66 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.24014512 |
67 | negative regulation of neurotransmitter transport (GO:0051589) | 3.23800958 |
68 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.23791029 |
69 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.23417500 |
70 | cell communication by electrical coupling (GO:0010644) | 3.21810677 |
71 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.21058340 |
72 | nucleotide transmembrane transport (GO:1901679) | 3.16598890 |
73 | negative regulation of protein localization to cell surface (GO:2000009) | 3.16406212 |
74 | acidic amino acid transport (GO:0015800) | 3.14935552 |
75 | cellular sodium ion homeostasis (GO:0006883) | 3.12503403 |
76 | positive regulation of Rap GTPase activity (GO:0032854) | 3.11951802 |
77 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.11542679 |
78 | signal peptide processing (GO:0006465) | 3.11036549 |
79 | adenosine receptor signaling pathway (GO:0001973) | 3.10906276 |
80 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.10324092 |
81 | regulation of synaptic plasticity (GO:0048167) | 3.07421413 |
82 | neuronal action potential propagation (GO:0019227) | 3.07067703 |
83 | vocalization behavior (GO:0071625) | 3.05661540 |
84 | L-amino acid import (GO:0043092) | 3.04270337 |
85 | synaptic transmission, glutamatergic (GO:0035249) | 3.03489855 |
86 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.02776843 |
87 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.99538443 |
88 | aromatic amino acid family catabolic process (GO:0009074) | 2.99422320 |
89 | positive regulation of synapse maturation (GO:0090129) | 2.98070030 |
90 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.96185669 |
91 | polyol transport (GO:0015791) | 2.96050428 |
92 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.95593358 |
93 | low-density lipoprotein particle remodeling (GO:0034374) | 2.95411200 |
94 | neurotransmitter transport (GO:0006836) | 2.94771784 |
95 | regulation of neurotransmitter secretion (GO:0046928) | 2.94570015 |
96 | auditory behavior (GO:0031223) | 2.93455607 |
97 | presynaptic membrane organization (GO:0097090) | 2.93447273 |
98 | long-term synaptic potentiation (GO:0060291) | 2.92357534 |
99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91855931 |
100 | glycerophospholipid catabolic process (GO:0046475) | 2.91638046 |
101 | cholesterol efflux (GO:0033344) | 2.90965387 |
102 | positive regulation of macrophage cytokine production (GO:0060907) | 2.89576649 |
103 | dendritic spine morphogenesis (GO:0060997) | 2.89233319 |
104 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87987241 |
105 | omega-hydroxylase P450 pathway (GO:0097267) | 2.87531393 |
106 | positive regulation of dendritic spine development (GO:0060999) | 2.87332814 |
107 | activation of protein kinase A activity (GO:0034199) | 2.87257430 |
108 | regulation of Rap GTPase activity (GO:0032317) | 2.85771893 |
109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.84791908 |
110 | response to auditory stimulus (GO:0010996) | 2.82748799 |
111 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.82698730 |
112 | L-glutamate transport (GO:0015813) | 2.80612201 |
113 | ER overload response (GO:0006983) | 2.79821681 |
114 | regulation of neurotransmitter transport (GO:0051588) | 2.79625403 |
115 | substantia nigra development (GO:0021762) | 2.78282972 |
116 | astrocyte development (GO:0014002) | 2.77588474 |
117 | nucleotide transport (GO:0006862) | 2.72831804 |
118 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.72605439 |
119 | regulation of neurotransmitter levels (GO:0001505) | 2.72563331 |
120 | long-term memory (GO:0007616) | 2.71924866 |
121 | regulation of cholesterol metabolic process (GO:0090181) | 2.70836754 |
122 | regulation of collateral sprouting (GO:0048670) | 2.70107869 |
123 | positive regulation of membrane potential (GO:0045838) | 2.69722027 |
124 | synaptic vesicle endocytosis (GO:0048488) | 2.67036381 |
125 | regulation of inclusion body assembly (GO:0090083) | 2.66804590 |
126 | myelination in peripheral nervous system (GO:0022011) | 2.66162222 |
127 | peripheral nervous system axon ensheathment (GO:0032292) | 2.66162222 |
128 | regulation of female receptivity (GO:0045924) | 2.65259995 |
129 | regulation of beta-amyloid formation (GO:1902003) | 2.65244427 |
130 | thioester biosynthetic process (GO:0035384) | 2.65099417 |
131 | acyl-CoA biosynthetic process (GO:0071616) | 2.65099417 |
132 | purine ribonucleotide transport (GO:0015868) | 2.65040592 |
133 | negative regulation of axonogenesis (GO:0050771) | 2.63332355 |
134 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.61189117 |
135 | neuron-neuron synaptic transmission (GO:0007270) | 2.60532539 |
136 | high-density lipoprotein particle remodeling (GO:0034375) | 2.60256475 |
137 | apical protein localization (GO:0045176) | 2.59543685 |
138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.57416164 |
139 | GPI anchor metabolic process (GO:0006505) | 2.57239820 |
140 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.57166128 |
141 | regulation of synaptic transmission (GO:0050804) | 2.57077524 |
142 | neuromuscular process controlling posture (GO:0050884) | 2.56724181 |
143 | signal complex assembly (GO:0007172) | 2.56581045 |
144 | bile acid biosynthetic process (GO:0006699) | 2.55914519 |
145 | response to lead ion (GO:0010288) | 2.55402191 |
146 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.54768050 |
147 | tyrosine metabolic process (GO:0006570) | 2.54429131 |
148 | heme transport (GO:0015886) | 2.54425035 |
149 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.53827559 |
150 | cholesterol metabolic process (GO:0008203) | 2.53570431 |
151 | coenzyme catabolic process (GO:0009109) | 2.53528488 |
152 | asymmetric protein localization (GO:0008105) | 2.52556009 |
153 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.52503265 |
154 | isoprenoid biosynthetic process (GO:0008299) | 2.52123628 |
155 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51833390 |
156 | layer formation in cerebral cortex (GO:0021819) | 2.51571968 |
157 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.51319167 |
158 | reverse cholesterol transport (GO:0043691) | 2.51160320 |
159 | glycosylceramide metabolic process (GO:0006677) | 2.50411858 |
160 | purine nucleotide transport (GO:0015865) | 2.49065452 |
161 | amino acid import (GO:0043090) | 2.47904008 |
162 | GPI anchor biosynthetic process (GO:0006506) | 2.46014476 |
163 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.42905595 |
164 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.41773332 |
165 | establishment of mitochondrion localization (GO:0051654) | 2.41690153 |
166 | glyoxylate metabolic process (GO:0046487) | 2.41566291 |
167 | protein carboxylation (GO:0018214) | 2.38596645 |
168 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.38596645 |
169 | sterol metabolic process (GO:0016125) | 2.36766905 |
170 | negative regulation of JUN kinase activity (GO:0043508) | 2.35610168 |
171 | bile acid metabolic process (GO:0008206) | 2.35166337 |
172 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.34666505 |
173 | mannosylation (GO:0097502) | 2.34374611 |
174 | myelin assembly (GO:0032288) | 2.32873637 |
175 | phospholipid efflux (GO:0033700) | 2.32669199 |
176 | cellular response to cholesterol (GO:0071397) | 2.32562207 |
177 | sperm capacitation (GO:0048240) | 2.31991564 |
178 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.31886970 |
179 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.31886970 |
180 | carbohydrate derivative transport (GO:1901264) | 2.31831798 |
181 | steroid biosynthetic process (GO:0006694) | 2.30727238 |
182 | L-serine metabolic process (GO:0006563) | 2.29277020 |
183 | amino acid salvage (GO:0043102) | 2.29042403 |
184 | L-methionine salvage (GO:0071267) | 2.29042403 |
185 | L-methionine biosynthetic process (GO:0071265) | 2.29042403 |
186 | alpha-linolenic acid metabolic process (GO:0036109) | 2.28325704 |
187 | regulation of bile acid biosynthetic process (GO:0070857) | 2.26211169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.58814080 |
2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.06353885 |
3 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.77204230 |
4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.64321871 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.55937044 |
6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.49303934 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39718674 |
8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.38533375 |
9 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37694654 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33676280 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.28758473 |
12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.27380114 |
13 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.18329797 |
14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12454912 |
15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07835077 |
16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.04641248 |
17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02965363 |
18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01747410 |
19 | KDM2B_26808549_Chip-Seq_K562_Human | 2.00360714 |
20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85902987 |
21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.85191590 |
22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82045734 |
23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.79529206 |
24 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.74698660 |
25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73870512 |
26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.70465967 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70264957 |
28 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69299884 |
29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65462294 |
30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.65458686 |
31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.65458686 |
32 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.65336335 |
33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62884041 |
34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58782729 |
35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58438098 |
36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.57059287 |
37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56185936 |
38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50042655 |
39 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49555933 |
40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48006259 |
41 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.47297373 |
42 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45595653 |
43 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41775927 |
44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40456337 |
45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40259421 |
46 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39782031 |
47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38506201 |
48 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38264144 |
49 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.36336231 |
50 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.35726498 |
51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34549977 |
52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32704306 |
53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31828065 |
54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30459189 |
55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28934161 |
56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27491902 |
57 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26660492 |
58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26405537 |
59 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.25891862 |
60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25650451 |
61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25026885 |
62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23917767 |
63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23917767 |
64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23665905 |
65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23032963 |
66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21858584 |
67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20768101 |
68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20243159 |
69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20072640 |
70 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19205328 |
71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18437568 |
72 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17505600 |
73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17028419 |
74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16550874 |
75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15999602 |
76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14548738 |
77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14415553 |
78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13571761 |
79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12938609 |
80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12387575 |
81 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12260613 |
82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11108980 |
83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11065636 |
84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09847578 |
85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09458908 |
86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09119898 |
87 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08029535 |
88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06953871 |
89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06837808 |
90 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06442931 |
91 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06390374 |
92 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06299394 |
93 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05936856 |
94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05826787 |
95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05683853 |
96 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04052606 |
97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03878789 |
98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03411277 |
99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02600713 |
100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02123796 |
101 | CBP_21632823_ChIP-Seq_H3396_Human | 1.01920192 |
102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01070025 |
103 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00015576 |
104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99872524 |
105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99422998 |
106 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99018712 |
107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98634986 |
108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98574482 |
109 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97318906 |
110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97067759 |
111 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96914379 |
112 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96690673 |
113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96552378 |
114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96429545 |
115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96339393 |
116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96102811 |
117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96072849 |
118 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.95820229 |
119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95431745 |
120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95339111 |
121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95224693 |
122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.95204495 |
123 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95201642 |
124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94878626 |
125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94294454 |
126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94007154 |
127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93030226 |
128 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93023290 |
129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92955069 |
130 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92612098 |
131 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91998672 |
132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91474070 |
133 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91014221 |
134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90742384 |
135 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89776298 |
136 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89768663 |
137 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89541764 |
138 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89521189 |
139 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.88667978 |
140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88602956 |
141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.88252735 |
142 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88247118 |
143 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87854678 |
144 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87679216 |
145 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87248681 |
146 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87208457 |
147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86996094 |
148 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86967690 |
149 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86286077 |
150 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86232452 |
151 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86075610 |
152 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86047402 |
153 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.85947064 |
154 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.85898688 |
155 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84994092 |
156 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84453235 |
157 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83845305 |
158 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.83061811 |
159 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81983250 |
160 | SPI1_23127762_ChIP-Seq_K562_Human | 0.80809794 |
161 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79246061 |
162 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78065736 |
163 | AR_19668381_ChIP-Seq_PC3_Human | 0.77743697 |
164 | P68_20966046_ChIP-Seq_HELA_Human | 0.77717739 |
165 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77290334 |
166 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76779508 |
167 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.76531420 |
168 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75969566 |
169 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75624139 |
170 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75061518 |
171 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74994704 |
172 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74994704 |
173 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.73348177 |
174 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.72896143 |
175 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.72796600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.30822778 |
2 | MP0000920_abnormal_myelination | 4.42105141 |
3 | MP0009840_abnormal_foam_cell | 4.32547699 |
4 | MP0005360_urolithiasis | 4.01978209 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.62437896 |
6 | MP0003195_calcinosis | 3.50899894 |
7 | MP0003635_abnormal_synaptic_transmissio | 3.29926290 |
8 | MP0003950_abnormal_plasma_membrane | 3.20289309 |
9 | MP0003690_abnormal_glial_cell | 3.16171701 |
10 | MP0005171_absent_coat_pigmentation | 2.89490154 |
11 | MP0004043_abnormal_pH_regulation | 2.70818419 |
12 | MP0002063_abnormal_learning/memory/cond | 2.69076663 |
13 | MP0003806_abnormal_nucleotide_metabolis | 2.68759602 |
14 | MP0009745_abnormal_behavioral_response | 2.59662777 |
15 | MP0003136_yellow_coat_color | 2.56981922 |
16 | MP0004885_abnormal_endolymph | 2.25209786 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.13814622 |
18 | MP0005167_abnormal_blood-brain_barrier | 2.13769733 |
19 | MP0005085_abnormal_gallbladder_physiolo | 2.10452046 |
20 | MP0002572_abnormal_emotion/affect_behav | 2.09832091 |
21 | MP0003634_abnormal_glial_cell | 2.09204824 |
22 | MP0008438_abnormal_cutaneous_collagen | 2.08803162 |
23 | MP0003303_peritoneal_inflammation | 2.02563950 |
24 | MP0005365_abnormal_bile_salt | 1.96752460 |
25 | MP0003329_amyloid_beta_deposits | 1.91911182 |
26 | MP0003879_abnormal_hair_cell | 1.86038013 |
27 | MP0001970_abnormal_pain_threshold | 1.82876655 |
28 | MP0001905_abnormal_dopamine_level | 1.82815281 |
29 | MP0009046_muscle_twitch | 1.82572557 |
30 | MP0003075_altered_response_to | 1.81610784 |
31 | MP0002735_abnormal_chemical_nociception | 1.79570117 |
32 | MP0001968_abnormal_touch/_nociception | 1.78909013 |
33 | MP0005058_abnormal_lysosome_morphology | 1.77996784 |
34 | MP0001502_abnormal_circadian_rhythm | 1.72729621 |
35 | MP0001501_abnormal_sleep_pattern | 1.72419659 |
36 | MP0002229_neurodegeneration | 1.71202365 |
37 | MP0005551_abnormal_eye_electrophysiolog | 1.68070886 |
38 | MP0008260_abnormal_autophagy | 1.63890498 |
39 | MP0002733_abnormal_thermal_nociception | 1.62695651 |
40 | MP0005409_darkened_coat_color | 1.60152245 |
41 | MP0005645_abnormal_hypothalamus_physiol | 1.58287946 |
42 | MP0004270_analgesia | 1.56110857 |
43 | MP0005408_hypopigmentation | 1.54747432 |
44 | MP0004742_abnormal_vestibular_system | 1.49298440 |
45 | MP0005332_abnormal_amino_acid | 1.48235390 |
46 | MP0002067_abnormal_sensory_capabilities | 1.47753833 |
47 | MP0001666_abnormal_nutrient_absorption | 1.47682622 |
48 | MP0004811_abnormal_neuron_physiology | 1.46544527 |
49 | MP0003632_abnormal_nervous_system | 1.46457248 |
50 | MP0004381_abnormal_hair_follicle | 1.42457189 |
51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.42160465 |
52 | MP0002118_abnormal_lipid_homeostasis | 1.38507262 |
53 | MP0004142_abnormal_muscle_tone | 1.37952449 |
54 | MP0005410_abnormal_fertilization | 1.37254962 |
55 | MP0003252_abnormal_bile_duct | 1.34384784 |
56 | MP0002272_abnormal_nervous_system | 1.33325255 |
57 | MP0004510_myositis | 1.31047026 |
58 | MP0002877_abnormal_melanocyte_morpholog | 1.30601398 |
59 | MP0002066_abnormal_motor_capabilities/c | 1.30445417 |
60 | MP0001486_abnormal_startle_reflex | 1.28487918 |
61 | MP0000604_amyloidosis | 1.28191605 |
62 | MP0001984_abnormal_olfaction | 1.25584134 |
63 | MP0009278_abnormal_bone_marrow | 1.24045705 |
64 | MP0004134_abnormal_chest_morphology | 1.21254185 |
65 | MP0001440_abnormal_grooming_behavior | 1.16499626 |
66 | MP0003631_nervous_system_phenotype | 1.16393313 |
67 | MP0008874_decreased_physiological_sensi | 1.14814035 |
68 | MP0003172_abnormal_lysosome_physiology | 1.13080879 |
69 | MP0005253_abnormal_eye_physiology | 1.11698527 |
70 | MP0004782_abnormal_surfactant_physiolog | 1.11256556 |
71 | MP0002557_abnormal_social/conspecific_i | 1.10153471 |
72 | MP0001177_atelectasis | 1.09218748 |
73 | MP0002822_catalepsy | 1.07899158 |
74 | MP0003787_abnormal_imprinting | 1.07466624 |
75 | MP0003011_delayed_dark_adaptation | 1.06634878 |
76 | MP0001661_extended_life_span | 1.05602404 |
77 | MP0005166_decreased_susceptibility_to | 1.05363303 |
78 | MP0005670_abnormal_white_adipose | 1.05327745 |
79 | MP0005451_abnormal_body_composition | 1.04762477 |
80 | MP0005195_abnormal_posterior_eye | 1.03722056 |
81 | MP0009780_abnormal_chondrocyte_physiolo | 1.03107308 |
82 | MP0000372_irregular_coat_pigmentation | 1.02253321 |
83 | MP0001346_abnormal_lacrimal_gland | 1.02021596 |
84 | MP0005646_abnormal_pituitary_gland | 1.01125991 |
85 | MP0001299_abnormal_eye_distance/ | 1.00801141 |
86 | MP0004130_abnormal_muscle_cell | 1.00764575 |
87 | MP0000647_abnormal_sebaceous_gland | 0.99635938 |
88 | MP0000462_abnormal_digestive_system | 0.99282109 |
89 | MP0003633_abnormal_nervous_system | 0.99163078 |
90 | MP0000747_muscle_weakness | 0.97193676 |
91 | MP0010329_abnormal_lipoprotein_level | 0.97193576 |
92 | MP0000566_synostosis | 0.95874690 |
93 | MP0002736_abnormal_nociception_after | 0.95505018 |
94 | MP0002638_abnormal_pupillary_reflex | 0.95476200 |
95 | MP0004924_abnormal_behavior | 0.95205368 |
96 | MP0005386_behavior/neurological_phenoty | 0.95205368 |
97 | MP0001529_abnormal_vocalization | 0.94742576 |
98 | MP0002152_abnormal_brain_morphology | 0.94198068 |
99 | MP0002295_abnormal_pulmonary_circulatio | 0.92751748 |
100 | MP0003183_abnormal_peptide_metabolism | 0.92516740 |
101 | MP0002090_abnormal_vision | 0.90661450 |
102 | MP0001485_abnormal_pinna_reflex | 0.90461938 |
103 | MP0006276_abnormal_autonomic_nervous | 0.89322643 |
104 | MP0000579_abnormal_nail_morphology | 0.89046796 |
105 | MP0002876_abnormal_thyroid_physiology | 0.88685365 |
106 | MP0001986_abnormal_taste_sensitivity | 0.87778613 |
107 | MP0000778_abnormal_nervous_system | 0.84403311 |
108 | MP0005083_abnormal_biliary_tract | 0.82503193 |
109 | MP0000003_abnormal_adipose_tissue | 0.79398650 |
110 | MP0008569_lethality_at_weaning | 0.79233214 |
111 | MP0005647_abnormal_sex_gland | 0.77797117 |
112 | MP0003724_increased_susceptibility_to | 0.75254590 |
113 | MP0002653_abnormal_ependyma_morphology | 0.75189864 |
114 | MP0001963_abnormal_hearing_physiology | 0.74132709 |
115 | MP0009643_abnormal_urine_homeostasis | 0.73779049 |
116 | MP0000639_abnormal_adrenal_gland | 0.72468341 |
117 | MP0005164_abnormal_response_to | 0.71554726 |
118 | MP0002064_seizures | 0.71486198 |
119 | MP0004019_abnormal_vitamin_homeostasis | 0.71425384 |
120 | MP0006082_CNS_inflammation | 0.71120340 |
121 | MP0002882_abnormal_neuron_morphology | 0.70831387 |
122 | MP0000749_muscle_degeneration | 0.70104954 |
123 | MP0001324_abnormal_eye_pigmentation | 0.69819340 |
124 | MP0002734_abnormal_mechanical_nocicepti | 0.69217275 |
125 | MP0004858_abnormal_nervous_system | 0.67944453 |
126 | MP0003186_abnormal_redox_activity | 0.67759060 |
127 | MP0000383_abnormal_hair_follicle | 0.66778008 |
128 | MP0005535_abnormal_body_temperature | 0.66445974 |
129 | MP0006072_abnormal_retinal_apoptosis | 0.66161709 |
130 | MP0010678_abnormal_skin_adnexa | 0.65690341 |
131 | MP0003880_abnormal_central_pattern | 0.64344852 |
132 | MP0002419_abnormal_innate_immunity | 0.64128921 |
133 | MP0000026_abnormal_inner_ear | 0.64111163 |
134 | MP0003453_abnormal_keratinocyte_physiol | 0.63964898 |
135 | MP0005671_abnormal_response_to | 0.63877782 |
136 | MP0005000_abnormal_immune_tolerance | 0.63733494 |
137 | MP0002752_abnormal_somatic_nervous | 0.63266664 |
138 | MP0000343_altered_response_to | 0.63260907 |
139 | MP0009384_cardiac_valve_regurgitation | 0.63040961 |
140 | MP0005423_abnormal_somatic_nervous | 0.62811560 |
141 | MP0000955_abnormal_spinal_cord | 0.62591516 |
142 | MP0003300_gastrointestinal_ulcer | 0.62249320 |
143 | MP0000609_abnormal_liver_physiology | 0.62115657 |
144 | MP0005379_endocrine/exocrine_gland_phen | 0.62104934 |
145 | MP0001764_abnormal_homeostasis | 0.62066426 |
146 | MP0003436_decreased_susceptibility_to | 0.61745867 |
147 | MP0005025_abnormal_response_to | 0.60154802 |
148 | MP0000751_myopathy | 0.58368075 |
149 | MP0003137_abnormal_impulse_conducting | 0.52706789 |
150 | MP0005174_abnormal_tail_pigmentation | 0.51169545 |
151 | MP0001851_eye_inflammation | 0.51033835 |
152 | MP0002184_abnormal_innervation | 0.50826981 |
153 | MP0003045_fibrosis | 0.50452635 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.45128308 |
2 | Neurofibrillary tangles (HP:0002185) | 5.27818775 |
3 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.93186581 |
4 | Abnormality of binocular vision (HP:0011514) | 4.72291738 |
5 | Diplopia (HP:0000651) | 4.72291738 |
6 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.61037885 |
7 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.61037885 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.48505019 |
9 | Focal motor seizures (HP:0011153) | 4.45908308 |
10 | Ankle clonus (HP:0011448) | 4.40448705 |
11 | Action tremor (HP:0002345) | 4.24597427 |
12 | Abnormal auditory evoked potentials (HP:0006958) | 4.04858784 |
13 | Intrahepatic cholestasis (HP:0001406) | 3.90870038 |
14 | Scanning speech (HP:0002168) | 3.71670949 |
15 | Focal seizures (HP:0007359) | 3.63533076 |
16 | Onion bulb formation (HP:0003383) | 3.62839349 |
17 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.59562346 |
18 | Hemiplegia (HP:0002301) | 3.53706001 |
19 | Mutism (HP:0002300) | 3.48280668 |
20 | Axonal loss (HP:0003447) | 3.44938641 |
21 | Neuronal loss in central nervous system (HP:0002529) | 3.37506747 |
22 | Cerebral inclusion bodies (HP:0100314) | 3.36482196 |
23 | Abnormal eating behavior (HP:0100738) | 3.33671375 |
24 | Obstructive sleep apnea (HP:0002870) | 3.32420590 |
25 | Xanthomatosis (HP:0000991) | 3.32167885 |
26 | Abnormality of the corticospinal tract (HP:0002492) | 3.23346354 |
27 | Postural instability (HP:0002172) | 3.14611989 |
28 | Papilledema (HP:0001085) | 2.99174237 |
29 | Parakeratosis (HP:0001036) | 2.97619419 |
30 | Prolonged neonatal jaundice (HP:0006579) | 2.97073232 |
31 | Epileptic encephalopathy (HP:0200134) | 2.93122645 |
32 | Febrile seizures (HP:0002373) | 2.89593062 |
33 | Supranuclear gaze palsy (HP:0000605) | 2.89458125 |
34 | Symptomatic seizures (HP:0011145) | 2.84382337 |
35 | Prolonged partial thromboplastin time (HP:0003645) | 2.83550205 |
36 | Annular pancreas (HP:0001734) | 2.82377699 |
37 | Hypoglycemic seizures (HP:0002173) | 2.79232071 |
38 | Abolished electroretinogram (ERG) (HP:0000550) | 2.77576341 |
39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69037982 |
40 | Generalized tonic-clonic seizures (HP:0002069) | 2.67688178 |
41 | Apathy (HP:0000741) | 2.67208801 |
42 | Epidermoid cyst (HP:0200040) | 2.65557762 |
43 | Rapidly progressive (HP:0003678) | 2.64429312 |
44 | Truncal ataxia (HP:0002078) | 2.64348070 |
45 | Cerebral hypomyelination (HP:0006808) | 2.63846009 |
46 | Hyperlipoproteinemia (HP:0010980) | 2.62910289 |
47 | Atonic seizures (HP:0010819) | 2.62865181 |
48 | Visual hallucinations (HP:0002367) | 2.62499346 |
49 | Peripheral hypomyelination (HP:0007182) | 2.62462496 |
50 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.61368732 |
51 | Aplasia of the phalanges of the hand (HP:0009802) | 2.61368732 |
52 | Aplasia involving bones of the extremities (HP:0009825) | 2.61368732 |
53 | Muscle fiber splitting (HP:0003555) | 2.61284257 |
54 | Abnormality of the periventricular white matter (HP:0002518) | 2.61225807 |
55 | Lower limb muscle weakness (HP:0007340) | 2.60979940 |
56 | Peripheral demyelination (HP:0011096) | 2.60100044 |
57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58942763 |
58 | Akinesia (HP:0002304) | 2.58393212 |
59 | Paraparesis (HP:0002385) | 2.55713669 |
60 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.52761187 |
61 | Rigidity (HP:0002063) | 2.50044253 |
62 | Diminished motivation (HP:0000745) | 2.48698770 |
63 | Premature rupture of membranes (HP:0001788) | 2.48606842 |
64 | Hyporeflexia of lower limbs (HP:0002600) | 2.46109692 |
65 | Tetraplegia (HP:0002445) | 2.44891917 |
66 | Intention tremor (HP:0002080) | 2.42569839 |
67 | Pigmentary retinal degeneration (HP:0001146) | 2.39270936 |
68 | Urinary urgency (HP:0000012) | 2.36144378 |
69 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.35825255 |
70 | Ocular albinism (HP:0001107) | 2.33447570 |
71 | Torticollis (HP:0000473) | 2.32686302 |
72 | Hemiparesis (HP:0001269) | 2.29680035 |
73 | Depression (HP:0000716) | 2.29432477 |
74 | Hypoglycemic coma (HP:0001325) | 2.28822553 |
75 | Bundle branch block (HP:0011710) | 2.26235969 |
76 | Bowel incontinence (HP:0002607) | 2.25896401 |
77 | Abnormality of glycine metabolism (HP:0010895) | 2.25511788 |
78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25511788 |
79 | Increased corneal curvature (HP:0100692) | 2.23776362 |
80 | Keratoconus (HP:0000563) | 2.23776362 |
81 | Hypokalemic alkalosis (HP:0001949) | 2.22749928 |
82 | Sensory axonal neuropathy (HP:0003390) | 2.22061077 |
83 | Foot dorsiflexor weakness (HP:0009027) | 2.22038366 |
84 | Retinal dysplasia (HP:0007973) | 2.20943307 |
85 | Hepatosplenomegaly (HP:0001433) | 2.20682267 |
86 | Abnormality of methionine metabolism (HP:0010901) | 2.20661816 |
87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19994209 |
88 | Increased cerebral lipofuscin (HP:0011813) | 2.18787225 |
89 | Dysdiadochokinesis (HP:0002075) | 2.18557959 |
90 | Memory impairment (HP:0002354) | 2.18151333 |
91 | Split foot (HP:0001839) | 2.17647995 |
92 | Insomnia (HP:0100785) | 2.16482813 |
93 | Pheochromocytoma (HP:0002666) | 2.15362074 |
94 | Clonus (HP:0002169) | 2.15299301 |
95 | Progressive neurologic deterioration (HP:0002344) | 2.13993062 |
96 | Hypophosphatemic rickets (HP:0004912) | 2.13832221 |
97 | Abnormal large intestine physiology (HP:0012700) | 2.13338105 |
98 | Fat malabsorption (HP:0002630) | 2.13133639 |
99 | Spastic paraparesis (HP:0002313) | 2.12679747 |
100 | Iris hypopigmentation (HP:0007730) | 2.11058136 |
101 | Premature skin wrinkling (HP:0100678) | 2.10201541 |
102 | Clumsiness (HP:0002312) | 2.09802933 |
103 | Thickened helices (HP:0000391) | 2.09448271 |
104 | Anomalous pulmonary venous return (HP:0010772) | 2.09230393 |
105 | Polyphagia (HP:0002591) | 2.08408128 |
106 | Abnormality of the foot musculature (HP:0001436) | 2.08266398 |
107 | Metabolic alkalosis (HP:0200114) | 2.07917244 |
108 | Bradykinesia (HP:0002067) | 2.07324268 |
109 | Fetal akinesia sequence (HP:0001989) | 2.06886743 |
110 | Progressive cerebellar ataxia (HP:0002073) | 2.06025824 |
111 | Dysostosis multiplex (HP:0000943) | 2.04973541 |
112 | Stereotypic behavior (HP:0000733) | 2.04181713 |
113 | Stridor (HP:0010307) | 2.04178048 |
114 | Choreoathetosis (HP:0001266) | 2.03670813 |
115 | Dementia (HP:0000726) | 2.01829497 |
116 | Termporal pattern (HP:0011008) | 2.01317666 |
117 | Insidious onset (HP:0003587) | 2.01317666 |
118 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.00208749 |
119 | Difficulty running (HP:0009046) | 1.99372547 |
120 | Vacuolated lymphocytes (HP:0001922) | 1.98688219 |
121 | Slow saccadic eye movements (HP:0000514) | 1.98067054 |
122 | Decreased motor nerve conduction velocity (HP:0003431) | 1.97938224 |
123 | Megalencephaly (HP:0001355) | 1.97536503 |
124 | Spastic tetraparesis (HP:0001285) | 1.97353794 |
125 | Protuberant abdomen (HP:0001538) | 1.96402238 |
126 | Focal dystonia (HP:0004373) | 1.96358128 |
127 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96130194 |
128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96130194 |
129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96130194 |
130 | Patchy hypopigmentation of hair (HP:0011365) | 1.95753654 |
131 | White forelock (HP:0002211) | 1.95507547 |
132 | Sleep apnea (HP:0010535) | 1.94074545 |
133 | Ventricular fibrillation (HP:0001663) | 1.93615610 |
134 | Joint hemorrhage (HP:0005261) | 1.92022832 |
135 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.91029421 |
136 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.90789140 |
137 | Deep venous thrombosis (HP:0002625) | 1.90020616 |
138 | Delusions (HP:0000746) | 1.89725122 |
139 | Craniofacial dystonia (HP:0012179) | 1.88006235 |
140 | Global brain atrophy (HP:0002283) | 1.87764242 |
141 | Increased circulating renin level (HP:0000848) | 1.87424616 |
142 | Urinary incontinence (HP:0000020) | 1.86603369 |
143 | Limb dystonia (HP:0002451) | 1.86187397 |
144 | Hypomagnesemia (HP:0002917) | 1.85422580 |
145 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85374568 |
146 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.84527885 |
147 | Heart block (HP:0012722) | 1.84381080 |
148 | Turricephaly (HP:0000262) | 1.83084194 |
149 | Hypoplasia of the iris (HP:0007676) | 1.82626780 |
150 | Dysmetria (HP:0001310) | 1.82489622 |
151 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82442775 |
152 | Hyperglycinuria (HP:0003108) | 1.81854797 |
153 | Absence seizures (HP:0002121) | 1.81553049 |
154 | Morphological abnormality of the inner ear (HP:0011390) | 1.81493368 |
155 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80486577 |
156 | Spastic paraplegia (HP:0001258) | 1.80122822 |
157 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79111893 |
158 | Submucous cleft hard palate (HP:0000176) | 1.79083311 |
159 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.79015766 |
160 | Hypoplasia of the fovea (HP:0007750) | 1.79015766 |
161 | Amyloidosis (HP:0011034) | 1.78630184 |
162 | Leukodystrophy (HP:0002415) | 1.78213902 |
163 | Hyperglycinemia (HP:0002154) | 1.78148019 |
164 | Confusion (HP:0001289) | 1.77846680 |
165 | Septo-optic dysplasia (HP:0100842) | 1.77669620 |
166 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77509368 |
167 | Absent septum pellucidum (HP:0001331) | 1.77182732 |
168 | Rickets (HP:0002748) | 1.76996445 |
169 | Generalized aminoaciduria (HP:0002909) | 1.76819664 |
170 | Alacrima (HP:0000522) | 1.76230496 |
171 | Spastic gait (HP:0002064) | 1.75792302 |
172 | Abnormality of the pulmonary veins (HP:0011718) | 1.75141691 |
173 | Anxiety (HP:0000739) | 1.75012781 |
174 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.74433662 |
175 | Bell-shaped thorax (HP:0001591) | 1.73969843 |
176 | Alkalosis (HP:0001948) | 1.73146532 |
177 | Large for gestational age (HP:0001520) | 1.72815853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 7.69956607 |
2 | STK39 | 4.46095973 |
3 | NTRK3 | 3.73828024 |
4 | EPHA4 | 3.22305322 |
5 | EPHB1 | 3.17411857 |
6 | NTRK2 | 3.09750520 |
7 | RIPK4 | 2.82818407 |
8 | MARK1 | 2.81106105 |
9 | OXSR1 | 2.78773129 |
10 | PBK | 2.31145237 |
11 | DAPK2 | 2.25830451 |
12 | WNK4 | 2.25275161 |
13 | PKN1 | 2.23294875 |
14 | TYRO3 | 2.12663164 |
15 | MAPKAPK5 | 2.11314567 |
16 | FGFR2 | 2.09001583 |
17 | INSRR | 2.02483483 |
18 | RIPK1 | 1.91078542 |
19 | MET | 1.90301982 |
20 | SGK494 | 1.87241625 |
21 | SGK223 | 1.87241625 |
22 | CAMKK1 | 1.81000709 |
23 | AKT3 | 1.71227871 |
24 | BCR | 1.68991869 |
25 | NEK6 | 1.68783205 |
26 | KSR2 | 1.64176254 |
27 | MAP3K11 | 1.61367981 |
28 | YES1 | 1.58238112 |
29 | MAPK15 | 1.56361201 |
30 | FES | 1.48560089 |
31 | MAP3K13 | 1.46681243 |
32 | WNK1 | 1.46430549 |
33 | CSNK1A1L | 1.45617437 |
34 | BMPR2 | 1.41612266 |
35 | PINK1 | 1.41273313 |
36 | MINK1 | 1.38849900 |
37 | ARAF | 1.37752420 |
38 | GSK3A | 1.33740965 |
39 | UHMK1 | 1.29093188 |
40 | MAP3K9 | 1.17256957 |
41 | DYRK2 | 1.13432876 |
42 | CAMK2B | 1.12214265 |
43 | CAMK2D | 1.10110301 |
44 | IRAK3 | 1.09799271 |
45 | ROCK2 | 1.09474691 |
46 | CSNK1G3 | 1.08163374 |
47 | PHKG1 | 1.08026887 |
48 | PHKG2 | 1.08026887 |
49 | LIMK1 | 1.05828578 |
50 | SIK2 | 1.03548941 |
51 | NTRK1 | 1.02666307 |
52 | CLK1 | 1.01690868 |
53 | CSNK1G1 | 0.99463808 |
54 | IRAK2 | 0.97989940 |
55 | PRKD3 | 0.97191880 |
56 | CAMK1 | 0.96768191 |
57 | EPHA3 | 0.91497641 |
58 | CAMK2G | 0.90956420 |
59 | TRPM7 | 0.88014747 |
60 | MAP3K1 | 0.86303859 |
61 | TESK2 | 0.85523789 |
62 | MAP4K1 | 0.85276001 |
63 | MAPK10 | 0.85010080 |
64 | MAP3K14 | 0.83617653 |
65 | CASK | 0.83105813 |
66 | STK11 | 0.81928921 |
67 | PRKCE | 0.81728681 |
68 | CDK15 | 0.78421726 |
69 | JAK2 | 0.78231931 |
70 | PDK1 | 0.77162020 |
71 | GRK1 | 0.76791126 |
72 | KSR1 | 0.76661582 |
73 | MOS | 0.75131468 |
74 | MAPK13 | 0.74989742 |
75 | MAPK7 | 0.73978401 |
76 | CDK11A | 0.73863193 |
77 | CDK19 | 0.71328123 |
78 | PRKCH | 0.71140877 |
79 | CDK18 | 0.70338586 |
80 | FYN | 0.69819249 |
81 | MUSK | 0.69234967 |
82 | GRK5 | 0.68856644 |
83 | BLK | 0.67556336 |
84 | CDK14 | 0.66314512 |
85 | ALK | 0.65818443 |
86 | CSNK1G2 | 0.65270267 |
87 | IRAK1 | 0.64407246 |
88 | TNIK | 0.64303456 |
89 | PIK3CA | 0.64222698 |
90 | CAMK4 | 0.62402949 |
91 | BCKDK | 0.61979809 |
92 | FRK | 0.60495962 |
93 | CSNK1A1 | 0.60231435 |
94 | PAK6 | 0.59799886 |
95 | RET | 0.58699155 |
96 | ERBB4 | 0.58659418 |
97 | MKNK1 | 0.58353128 |
98 | LATS2 | 0.58105295 |
99 | ICK | 0.57799027 |
100 | CDK5 | 0.57369585 |
101 | IRAK4 | 0.57320925 |
102 | CAMK2A | 0.56798310 |
103 | JAK1 | 0.56708879 |
104 | MAPK4 | 0.55574395 |
105 | PRKD1 | 0.55507411 |
106 | PRKCQ | 0.55465439 |
107 | PAK3 | 0.55439838 |
108 | PLK2 | 0.54549410 |
109 | TYK2 | 0.54030958 |
110 | SIK1 | 0.53971739 |
111 | PRKCG | 0.53652548 |
112 | MAP3K2 | 0.53493829 |
113 | TRIB3 | 0.51177174 |
114 | SYK | 0.51074024 |
115 | TAOK2 | 0.50588049 |
116 | MAP2K2 | 0.50522266 |
117 | BMPR1B | 0.48998704 |
118 | SGK3 | 0.46549267 |
119 | RAF1 | 0.46465253 |
120 | CAMK1G | 0.46028314 |
121 | RPS6KA3 | 0.45604098 |
122 | ZAP70 | 0.45036364 |
123 | CAMK1D | 0.44805848 |
124 | HIPK2 | 0.44432359 |
125 | MKNK2 | 0.43724717 |
126 | CAMKK2 | 0.43673286 |
127 | PRKACB | 0.43300212 |
128 | SGK2 | 0.41721484 |
129 | FGR | 0.41682724 |
130 | ROCK1 | 0.41636171 |
131 | PRKG1 | 0.40694353 |
132 | DYRK1A | 0.40605937 |
133 | DAPK3 | 0.39358911 |
134 | MAPK12 | 0.38233409 |
135 | INSR | 0.38190229 |
136 | PDGFRA | 0.38062361 |
137 | PRKCZ | 0.37841160 |
138 | TNK2 | 0.37601191 |
139 | PRKG2 | 0.35161002 |
140 | DDR2 | 0.34954413 |
141 | CDC42BPA | 0.34282922 |
142 | ITK | 0.33696988 |
143 | SGK1 | 0.33660745 |
144 | PRKACA | 0.33270056 |
145 | MST4 | 0.33025665 |
146 | PRKAA1 | 0.32614723 |
147 | PDPK1 | 0.32533007 |
148 | WNK3 | 0.31974474 |
149 | DYRK1B | 0.31141610 |
150 | PRKAA2 | 0.29763342 |
151 | CSK | 0.29731186 |
152 | CDK3 | 0.29578070 |
153 | CSNK1D | 0.29399008 |
154 | ZAK | 0.29085833 |
155 | ERBB2 | 0.28869359 |
156 | MARK2 | 0.28436455 |
157 | PRKACG | 0.27997475 |
158 | BMX | 0.27366424 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.94297367 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.85412489 |
3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.60510360 |
4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.24111845 |
5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.17322435 |
6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.96122774 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88022734 |
8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.83654002 |
9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67713898 |
10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.46022141 |
11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.45355362 |
12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.29571808 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.26535711 |
14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.25982712 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15283963 |
16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.13938365 |
17 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13799502 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09101245 |
19 | Protein export_Homo sapiens_hsa03060 | 2.01503173 |
20 | Morphine addiction_Homo sapiens_hsa05032 | 2.00612566 |
21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.95393811 |
22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94835163 |
23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88980240 |
24 | Insulin secretion_Homo sapiens_hsa04911 | 1.81694486 |
25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.80406732 |
26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.79399277 |
27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73668023 |
28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.66778254 |
29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61179576 |
30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60162296 |
31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.55655632 |
32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54930511 |
33 | Peroxisome_Homo sapiens_hsa04146 | 1.52857249 |
34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51002509 |
35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46236641 |
36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44850594 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44233861 |
38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.42783335 |
39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41547928 |
40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.40651601 |
41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39821070 |
42 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.37982654 |
43 | Renin secretion_Homo sapiens_hsa04924 | 1.36075352 |
44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35234116 |
45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.34781667 |
46 | Salivary secretion_Homo sapiens_hsa04970 | 1.33297783 |
47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31374740 |
48 | Lysosome_Homo sapiens_hsa04142 | 1.30016330 |
49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29830669 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25251961 |
51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22882346 |
52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22288738 |
53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21030557 |
54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20867249 |
55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19061782 |
56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17957279 |
57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17323092 |
58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16385723 |
59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15733572 |
60 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15561994 |
61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15378317 |
62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14349216 |
63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12845442 |
64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12633410 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10669374 |
66 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.10272925 |
67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09294359 |
68 | Glioma_Homo sapiens_hsa05214 | 1.09217114 |
69 | ABC transporters_Homo sapiens_hsa02010 | 1.09013909 |
70 | Long-term depression_Homo sapiens_hsa04730 | 1.02514086 |
71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02245605 |
72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01553904 |
73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00651703 |
74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98933229 |
75 | Gap junction_Homo sapiens_hsa04540 | 0.98107317 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97251233 |
77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95697706 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95184513 |
79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93469152 |
80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92828038 |
81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91156882 |
82 | Melanogenesis_Homo sapiens_hsa04916 | 0.90391290 |
83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90018625 |
84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89385939 |
85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87989142 |
86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87108649 |
87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85766731 |
88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85194635 |
89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85166673 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84458764 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.83853842 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.83573448 |
93 | Tuberculosis_Homo sapiens_hsa05152 | 0.83317740 |
94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82427311 |
95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82236844 |
96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82118406 |
97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81548938 |
98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77541350 |
99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76898729 |
100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76277488 |
101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76024594 |
102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75089146 |
103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74647571 |
104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72514245 |
105 | Bile secretion_Homo sapiens_hsa04976 | 0.70886978 |
106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70437440 |
107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70052679 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69652676 |
109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69378877 |
110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69051628 |
111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66659353 |
112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65522649 |
113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64019983 |
114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63681213 |
115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62042232 |
116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58977798 |
117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58924521 |
118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58878718 |
119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58219682 |
120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57408644 |
121 | Taste transduction_Homo sapiens_hsa04742 | 0.56499424 |
122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56490414 |
123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56241693 |
124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56155984 |
125 | Salmonella infection_Homo sapiens_hsa05132 | 0.55770140 |
126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55758652 |
127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55073354 |
128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53976170 |
129 | Pertussis_Homo sapiens_hsa05133 | 0.53693801 |
130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52475101 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52320232 |
132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52212469 |
133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51892050 |
134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51343184 |
135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50993529 |
136 | Allograft rejection_Homo sapiens_hsa05330 | 0.50354991 |
137 | Phototransduction_Homo sapiens_hsa04744 | 0.50352762 |
138 | Prion diseases_Homo sapiens_hsa05020 | 0.49707754 |
139 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49124012 |
140 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49107182 |
141 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48252258 |
142 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47540779 |
143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44658466 |
144 | Phagosome_Homo sapiens_hsa04145 | 0.44071704 |
145 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43930846 |
146 | Axon guidance_Homo sapiens_hsa04360 | 0.43830864 |
147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43539562 |
148 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41554343 |
149 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40671999 |
150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32591284 |
151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31949524 |
152 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31660927 |
153 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30733970 |
154 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.28379580 |
155 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25836561 |
156 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25249259 |
157 | Tight junction_Homo sapiens_hsa04530 | 0.24907052 |
158 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24517306 |
159 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22586783 |
160 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20704851 |
161 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20605891 |
162 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19957137 |
163 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.19024791 |
164 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17699804 |
165 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.16883049 |
166 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16265610 |
167 | Malaria_Homo sapiens_hsa05144 | 0.15878953 |
168 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15822981 |
169 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15242684 |
170 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.15098664 |
171 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13936180 |
172 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.13851312 |
173 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13270467 |
174 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.12139155 |